The JBL Group
Solving Complex Reimbursement, Pricing and Health Policy Issues Across Canada
The JBL Group is one of Canada’s largest consultancies providing specialized services to the Pharmaceutical and related Health Care sectors. Our unique combination of expertise, experience and industry-knowledge means we understand our clients needs and can deliver top-quality results in Market Access Strategy, Pricing and Reimbursement, Advocacy and Stakeholder Relations, Government Relations, and Health Policy.
We offer our corporate and organizational clients a group of highly qualified consultants and professionnals who work as an integrated team and who bring to each challenge a wealth of experience in resolving complex business issues, quickly and effectively tailoring our services and expertise to their specific needs, from providing top-level strategic advice to hands-on program management and implementation.
JBL Group consultants are available in all of Canada’s major markets to serve our clients’ needs, nation-wide.
Founded in 2006, The JBL Group was created from the merger of two of Canada’s prominent healthcare consultancies, JBL & Associates and The Glenn Group. Over the years, we have grown to number 17 professionals across Canada, served some 150 different clients and worked on over 600 projects, making us the leading consulting firm of our type in the country.
Our projects have covered all major pharmaceutical prescription and non-prescription therapeutic categories as well as diagnostics and medical devices.
We have also worked with a variety of health care organizations, including patient groups, professional and industry associations and championed treatments for rare diseases.
Projects have included full Product Submissions to the Common Drug Review, INESSS, pCODR, provincial drug plans and private payers. We have also completed Financial-Impact Analyses, Market Access Strategic Plans and Reimbursement Strategy development for both new and existing products and at the provincial and federal levels. The JBL Group has experience with the new Pan-Canadian Pricing Alliance (PCPA) and in guiding clients to successfully negotiate Product Listing Agreements (PLAs).
We have negotiated price increases for individual companies and associations. In addition, our consultants have acted as facilitators between the industry and the government, as well as between individual manufacturers and - as experts in that domain - they are frequently invited to participate in industry forums.
The JBL Group is Canada’s leading consulting partner for Reimbursement, Pricing and Health Policy.
We offer our corporate and organizational clients a group of highly qualified consultants and professionnals who work as an integrated team and who bring to each challenge a wealth of experience in resolving complex business issues, quickly and effectively tailoring our services and expertise to their specific needs, from providing top-level strategic advice to hands-on program management and implementation.
JBL Group consultants are available in all of Canada’s major markets to serve our clients’ needs, nation-wide.
Founded in 2006, The JBL Group was created from the merger of two of Canada’s prominent healthcare consultancies, JBL & Associates and The Glenn Group. Over the years, we have grown to number 17 professionals across Canada, served some 150 different clients and worked on over 600 projects, making us the leading consulting firm of our type in the country.
Our projects have covered all major pharmaceutical prescription and non-prescription therapeutic categories as well as diagnostics and medical devices.
We have also worked with a variety of health care organizations, including patient groups, professional and industry associations and championed treatments for rare diseases.
Projects have included full Product Submissions to the Common Drug Review, INESSS, pCODR, provincial drug plans and private payers. We have also completed Financial-Impact Analyses, Market Access Strategic Plans and Reimbursement Strategy development for both new and existing products and at the provincial and federal levels. The JBL Group has experience with the new Pan-Canadian Pricing Alliance (PCPA) and in guiding clients to successfully negotiate Product Listing Agreements (PLAs).
We have negotiated price increases for individual companies and associations. In addition, our consultants have acted as facilitators between the industry and the government, as well as between individual manufacturers and - as experts in that domain - they are frequently invited to participate in industry forums.
The JBL Group is Canada’s leading consulting partner for Reimbursement, Pricing and Health Policy.